Immunogenic polypeptide cocktail for the treatment of medullary thyroid carcinoma
AssigneeTimothy Andrew Erickson
InventorTimothy Andrew Erickson
Life of this patent
Estimating the term…
Abstract
Disclosed are immunogenic compositions that include one or more polypeptides that, when administered to a subject with adjuvant, elicit an immune response against medullary thyroid cancer. Disclosed are methods of eliciting an immune response and/or treating cancer, such as medullary thyroid carcinoma or other thyroid carcinomas.
Claims6
A method of treating a subject who has medullary thyroid cancer by administering to the subject an immunogenic composition, which comprises SEQ ID NO:
- 2 in a suitable carrier and/or adjuvant.
A method of treating a subject who has medullary thyroid cancer by administering to the subject an immunogenic composition, which consists of SEQ ID NO:
- 2 and SEQ. ID NO:
- 28 in a suitable carrier and/or adjuvant.
A method of treating a subject who has medullary thyroid cancer by administering to the subject an immunogenic composition, which comprises cDNA or mRNA encoding SEQ. ID NO:
- 2.
A method of treating a subject who has medullary thyroid cancer by administering to the subject an immunogenic composition, which consists of cDNA or mRNA encoding SEQ. ID NO:
- 2 and SEQ. ID NO:
- 28.
Dependencies are inferred from the claim text.